Cardiovascular effects of endogenous opiate systems.
D000818:Animals; D001921:Brain / Q000502:physiology*; D002545:Brain Ischemia / Q000188:drug therapy; D002320:Cardiovascular Physiological Phenomena; D002319:Cardiovascular System / Q000187:drug effects; D004723:Endorphins / Q000494:pharmacology / Q000502:physiology*; D004745:Enkephalins / Q000502:physiology; D006801:Humans; D006973:Hypertension / Q000188:drug therapy; D007022:Hypotension / Q000188:drug therapy; D009020:Morphine / Q000494:pharmacology*; D009270:Naloxone / Q000494:pharmacology; D011311:Pressoreceptors / Q000502:physiology; D011957:Receptors, Opioid / Q000502:physiology; D012018:Reflex / Q000187:drug effects; D012769:Shock / Q000188:drug therapy*; D012771:Shock, Hemorrhagic / Q000188:drug therapy; D012772:Shock, Septic / Q000188:drug therapy; D013119:Spinal Cord Injuries / Q000188:drug therapy; D013973:Thyrotropin-Releasing Hormone / Q000502:physiology*
D004723:Endorphins; D004745:Enkephalins; D011957:Receptors, Opioid; D009270:Naloxone; D013973:Thyrotropin-Releasing Hormone; D009020:Morphine